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Abstract
The periaqueductal gray (PAG) has been reported to be a location for opioid regulation of pain and a potential site for behavioral 
selection in females. Opioid-mediated behavioral and physiological responses differ according to the activity of opioid receptor 
subtypes. The present study investigated the effects of the peripheral injection of the kappa-opioid receptor agonist U69593 into 
the dorsal subcutaneous region of animals on maternal behavior and on Oprk1 gene activity in the PAG of female rats. Female 
Wistar rats weighing 200-250 g at the beginning of the study were randomly divided into 2 groups for maternal behavior and 
gene expression experiments. On day 5, pups were removed at 7:00 am and placed in another home cage that was distant 
from their mother. Thirty minutes after removing the pups, the dams were treated with U69593 (0.15 mg/kg, sc) or 0.9% saline 
(up to 1 mL/kg) and after 30 min were evaluated in the maternal behavior test. Latencies in seconds for pup retrieval, grouping, 
crouching, and full maternal behavior were scored. The results showed that U69593 administration inhibited maternal behavior 
(P < 0.05) because a lower percentage of U69593 group dams showed retrieval of first pup, retrieving all pups, grouping, crouch-
ing and displaying full maternal behavior compared to the saline group. Opioid gene expression was evaluated using real-time 
reverse-transcription polymerase chain reaction (RT-PCR). A single injection of U69593 increased Oprk1 PAG expression in 
both virgin (P < 0.05) and lactating female rats (P < 0.01), with no significant effect on Oprm1 or Oprd1 gene activity. Thus, 
the expression of kappa-opioid receptors in the PAG may be modulated by single opioid receptor stimulation and behavioral 
meaningful opioidergic transmission in the adult female might occur simultaneously to specific changes in gene expression of 
kappa-opioid receptor subtype. This is yet another alert for the complex role of the opioid system in female reproduction.
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Opioidergic stimuli modulate various sensory systems 
with behavioral consequences for both male and female 
mammals (1-9). The periaqueductal gray (PAG) is likely 
to influence a number of brainstem sites that are critically 
involved in controlling both somatomotor (e.g., mating) and 
autonomic (e.g., thermoregulation) responses, as well as 
hypothalamic regions related to the control of generalized 
arousal and sensorimotor integration (10,11). The PAG is 
also known to play important roles in the modulation of 
nociceptive sensory transmission, regulation of the car-
diovascular system (12), vocalization (13), and expression 
of a variety of behaviors, including defensive (14), sexual 
(15), maternal (16-18), and feeding behaviors (15,19,20). 
The PAG occupies a pivotal position in the central nervous 
system that influences the selection of adaptive behavioral 
responses. This region receives both limbic information and 
a vast array of inputs from prefrontal cortical areas (21,22). 
Previous studies from our laboratory have suggested an 
integrative role of opioidergic transmission in the PAG in 
influencing behavioral selection during lactation (6,23-25). 
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The role played by the PAG in maternal behavior may be 
dependent on adequate local expression of opioid-related 
genes.
Opioid receptors have been the focus of intense mo-
lecular, physiological, and pharmacological research. The 
PAG has a high density of opioid receptors and activa-
tion of these metabotropic, G-protein-coupled receptors 
modulates various aspects of reproductive behavior in 
females. There are three types of opioid receptors: mu, 
delta, and kappa (26). Multiple reproductive experiences 
influence both gene activity and opioid receptor expression 
in the PAG. A preliminary study suggested that opioidergic 
stimulation modulates opioid gene expression in the female 
PAG (27,28).
Our group has shown that the morphine-induced inhibi-
tion of maternal behavior is plastic and adaptive and that 
opioidergic transmission in the rostral PAG plays a role in 
this process. In addition, it has been demonstrated that 
both repeated treatment with morphine and reproductive 
experience have effects on the expression of opioid recep-
tors. The present study further extends this line of research 
by investigating the hypothesis that one stimulation would 
modify the activity of a specific receptor gene. Although the 
major target of morphine and naloxone is Oprm1, the acute 
inhibition of maternal behavior induced by kappa receptor 
stimulation needs more investigation. Because kappa stimu-
lation is behaviorally meaningful, this study was designed to 
specifically investigate the dynamics of kappa on the PAG. 
In order to test for indirect or nonspecific effects, the kappa 
activity of Oprm1 and Oprd1 was also measured. 
The present study investigated the effects of U69593, a 
kappa-opioid receptor agonist, on mu-, kappa-, and delta-
opioid receptor Oprm1, Oprk1, and Oprd1 gene activity in 
the PAG of both lactating and virgin female rats. This was 
performed by evaluating opioid gene expression using 
real-time reverse-transcription polymerase chain reaction 
(RT-PCR).
The aim of the present study was to determine whether 
a single kappa opioidergic stimulation using the kappa 
agonist U69593 can promote immediate changes in the 
activity and expression of the kappa-opioid receptor gene 
in the PAG of female animals. In order to test for indirect 
effects of such kappa stimulation on other opioid receptor 
genes, the activity of mu and delta receptor genes was 
also measured. Both virgin and lactating rats were tested 
to determine whether the physiological state influences the 
response to this agonist.
Material and Methods
Animals and housing
Female Wistar rats weighing 200-250 g at the beginning 
of the study were obtained from Faculdade de Medicina 
Veterinária, Universidade de São Paulo. The animals were 
housed in polypropylene cages (32 x 40 x 18 cm) with 3 
animals per cage, under conditions of controlled temperature 
(22 ± 2°C), a 12/12-h light/dark cycle (lights on at 6:00 am), 
and free access to food and water during the experimental 
procedure. All animal procedures were in accordance with 
the guidelines of the Committee on the Care and Use of 
Laboratory Animal Resources, National Research Council, 
USA. We attempted to minimize the number of rats used, 
and every effort was made to ensure that no rat suffered 
unnecessarily.
For mating, 2 female rats were placed overnight with 
1 sexually experienced male rat. The day on which sperm 
was observed in the vaginal lavage was designated day 1 
of pregnancy. Pregnant rats were housed 2 per cage until 
day 18 of pregnancy and then individually until the end of 
the experiments. At parturition, all pups were examined 
externally, sexed, and weighed, with 8 pups (4 males and 
4 females) left with each dam until the maternal behavior 
test (experiment 1) and gene expression studies (experi-
ment 2).
Maternal tasks
On day 5 of lactation, pups were removed at 7:00 am 
and placed in another home cage that was distant from 
their mother. Thirty minutes after removing the pups, the 
dams were acutely challenged with U69593 ([5-α,7-α,8-β]-
[+]-N-methyl-N-{7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl}
benzeneacetamide; Sigma Aldrich, USA, 0.15 mg/kg, sc) 
or saline. Thirty minutes after the injections were given to 
the dams, all pups were placed back with their mothers, and 
maternal behavior testing began. Latencies in seconds for 
pup sniffing, retrieval, grouping, crouching, and full maternal 
behavior were scored (2,3). Animals were scored as fully 
maternal if they retrieved all 8 pups to the nest and displayed 
nursing behavior with their back arched over the pups for 
3 consecutive minutes. If animals were not fully maternal 
after 30 min of continuous observation, they were checked 
every 15 min up to 60 min and then hourly until full maternal 
behavior was observed. Events observed after the first 30 
min of continuous observation were recorded at the time 
of first observation (e.g., if full maternal behavior was first 
observed at 60 min, the full maternal behavior latency was 
scored as 60 min, or 3600 s). The same criterion was used 
for all other responses. For all behavioral tests, the observ-
ers were blind to the treatment of the test subjects.
Opioid-selective agonist treatment
Sixty virgin and lactating rats were randomly divided into 
two (experiment 1) and four (experiment 2) groups of 10 
animals each. They were treated with U69593 (0.15 mg/kg), 
saline, or no treatment (i.e., no experimental procedures 
were conducted on these animals, which were defined as 
blank). Brains were collected on day 5 of lactation. After 1 
h, the animals were decapitated for PAG dissection using a 
blade dissecting approximately 2 cm2 around the coordinate 
anteroposterior: 6.0; dorsoventral: 4.3; mediolateral: 0.6 
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coordinates (29). In both experiment, because the results 
for the saline and no treatment (blank) groups were similar 
(P > 0.5), they are presented as a single group (N = 10). 
RNA extraction, cDNA construction, and real-time 
RT-PCR quantification of opioid gene expression
Total RNA was extracted from each tissue sample using 
TRIZOL reagent (Invitrogen Life Technologies, USA). Thus, 
immediately after euthanasia by decapitation, the PAG (ap-
proximately 40 mg, removed with a scalpel) was suspended 
in 1 mL ice-cold TRIZOL, and total RNA was extracted 
according to manufacturer instructions. The final RNA 
pellets were resuspended in 50 µL diethyl-pyrocarbonate-
treated water. The total RNA concentrations were measured 
spectrophotometrically at 260 nm, and the integrity of RNA 
samples was analyzed on 1.5% agarose gel (Sigma, USA) 
containing ethidium bromide (0.5 µg/mL). Total RNA was 
then treated with DNase I before further processing and 
stored at -80°C.
Oligo DT primers (1 µL) and dNTPs (1 µL) were added 
to the total RNA sample (5 µg) and incubated at 65°C for 
5 min; 5X buffer (4 µL; Superscript II RNase H-reverse 
transcriptase), DTT (1 M, 2 µL), and RNaseOUT (1 µL) 
were then added, and the mixture was incubated at 42°C 
for 2 min. Superscript II (1 µL) was added and the mixture 
was incubated at 42°C for 50 min. An additional incubation 
was performed at 70°C for 15 min. One microliter RNaseH 
was added for the removal of remaining RNA and the mix-
ture was incubated at 37°C for 20 min. All reagents were 
purchased from Invitrogen Life Technologies.
Real-time RT-PCR was performed using an ABI Prism 
7000 Sequence Detection System (Applied Biosystems, 
USA) with TaqMan Universal Master Mix (part No. 4304437; 
Applied Biosystems). PCR primers (Applied Biosystems) 
and the TaqMan probes for Oprm1, Oprd1, Oprk1, and 
18S quantification were selected using the Primer Express 
software (Applied Biosystems), verified by a BLAST search 
of GenBank, and labeled Rn00565144_m1 for Oprm1, 
Rn00567737_m1 for Oprk1, RN00561699_m1 for Oprd1, 
and 4319413E for 18S, which was used as a housekeep-
ing control. The primers were chosen to amplify a 65-bp 
fragment. The internal TaqMan probe (FAM-3’-TCTGGGCA 
CCTCTCTTT-5’-NFQ) was designed following the general 
rules outlined by the manufacturer and carried a 5’-reporter 
dye [6-carboxy fluorescein (FAM)] and a 3’-non-fluorescent 
quencher dye (NFQ). The primers and probes were used 
with 100% efficiency at final concentrations of 0.9 and 0.25 
µM, respectively.
The thermal cycling conditions for cDNA quantification 
assays were established according to ABI Prism 7000 
Sequence Detection System parameters. Relative gene ex-
pression data were analyzed by the 2-ΔΔCT method (30).
Statistical analysis
Behavioral data were analyzed by comparing the means 
using the Student t-test. The percents of animals showing 
each behavior during the 30-min test were compared by 
the Fisher test. Mean gene expression data were compared 
by the Student t-test. Values of P < 0.05 were considered 
to be statistically significant.
Results
Experiment 1 
The 0.15 mg/kg dose of U69593 induced no sedation. 
Comparison of the saline and U69593 groups revealed that 
a lower percentage of U69593 group dams showed retrieval 
of first pup, and retrieving all pups, grouping, crouching and 
displaying full maternal behavior. Importantly, latencies to 
sniff the pups did not differ among groups (Table 1). Animals 
in the U69593 group continued digging in the wood chips 
and building nests instead of retrieving pups, resulting in 
longer latencies to retrieve the pups. Such disruptive effects 
were not observed in the saline group.
Experiment 2 
Acute U69593 treatment significantly increased Oprk1 
expression in virgin female rats (P < 0.05). This treatment 
did not induce alterations in Oprd1 or Oprm1 gene expres-
sion in the PAG of virgin female rats (Figure 1). In lactat-
ing female rats, U69593 treatment increased only Oprk1 
expression (P < 0.01). No other significant differences were 
found in opioid receptor gene expression in lactating rats 
treated with this drug (Figure 1) in the PAG. 
Discussion
The PAG belongs to a primary anatomical pathway me-
Table 1. Effects of treatment with a selective agonist kappa-opioid receptor (U69593) on maternal behavior on day 
5 of lactation.
Groups Latency to sniff
the 1st pup (s)
Retrieving 1st
pup
Retrieving all
pups
Grouping Crouching Full maternal 
behavior
Saline 10 ± 2.8 100 100 100 100 100
U69593 (0.15 mg/kg) 12 ± 3.4   50*    0*    0*    0*    0*
Data are reported as percentage of animals observed showing the listed behaviors during the first 30 min. Latency 
to sniff the first pup is reported in seconds (s). *P < 0.05 compared to the saline group (Fisher test).
Kappa-opioid receptors 985
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diating opioid-based analgesia. Morphine administration 
produces greater antinociception in males than females 
(31). In reproductive females, physiological activation 
of one or more PAG opioid receptors interferes with 
nursing and other aspects of maternal behavior, such as 
pup retrieval and pup grooming. The physiological role 
of female PAG opioid receptors, particularly the kappa 
receptor, has not been well established. The ventrolat-
eral PAG column of the caudal part might be involved 
in the expression of kyphosis toward pups, which is the 
arched-back posture that facilitates nursing (17). Mater-
nal aggression and survival strategies involving stressful 
situations have also been reported to be influenced by 
opioid receptors (16,17,32). A previous study reported 
that stimulation of kappa-opioid receptors using different 
doses of U69593 interferes with maternal behavior (8). 
Behavioral data reported in the present study show that 
peripheral injection of 0.15 mg/kg of the kappa agonist 
inhibits maternal behavior in lactating rats. On the other 
hand, other investigators administered a kappa 1 agonist 
(U69596, 0.1 mg/kg) and found no effect on maternal 
behavior in lactating rats. The larger dose used in the 
present study may be responsible for this difference. 
Alternatively, since another drug was used, kinetic dif-
ferences may have played a role (33). 
A previous study from our laboratory has reported the 
presence of kappa receptor protein in the PAG of both 
virgin and lactating rats (8). The present study investi-
gated the expression of Oprm1, Oprk1, and Oprd1 in the 
PAG of female rats by evaluating the gene expression 
of mu-, kappa-, and delta-opioid receptors in the PAG of 
animals treated with an acute injection of U69593. The 
present data suggest that agonist-induced changes in 
gene expression are similar in both lactating and virgin 
animals. Treatment with a single peripheral injection of 
the kappa-opioid agonist U69593 significantly increased 
kappa receptor gene expression in both lactating and vir-
gin rats. No significant changes were observed for mu or 
delta receptor genes after this drug challenge. Consistent 
with its binding affinity for kappa receptors, this action 
of U69593 on Oprk1 gene activity suggests a specificity 
of U69593 for actions on the gene encoding the kappa 
receptor. In the present study, the behavioral effects of 
acute kappa opioidergic stimulation in lactating rats were 
confirmed. In addition, the present data add knowledge to 
this scenario by demonstrating a specific effect of a kappa 
agonist on a site that has been functionally implicated in 
behavioral selection during lactation. Acute stimulation 
increased Oprk1 gene activity in both virgin and lactating 
animals. This may indicate a lack of endocrine modula-
tion of this response. Thus, a specific immediate and 
likely compensatory gene response to kappa receptor 
stimulation is described in animals acutely exposed to 
a low dose of U69593. Such response may play a role 
in plastic mechanisms, resulting in different responses 
to similar pharmacological challenges. This hypothesis 
is to be tested in future studies. 
The present study shows that by stimulating a kappa-
opioid receptor both inhibition of maternal behavior and 
enhancement of Oprk1 are achieved. Although more stud-
Figure 1. Real-time RT-PCR of 5 µg total RNA extracted from the periaqueductal gray of adult virgin (A, B, C) and lactating female rats 
(D, E, F) in relation to expression of Oprm1, Oprk1 and Oprd1. Data are reported as means ± SEM. *P < 0.05 compared to the blank 
group (ANOVA).
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ies are necessary to elucidate the functional relationship 
between these effects, a specific role for the kappa receptor 
in the context of reproductive behavior now seems feasible. 
This is yet another alert for the complex role of the opioid 
system in female reproduction.
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